
### [NCIT:C4839](http://purl.obolibrary.org/obo/NCIT_C4839)
**Label:** Esophageal Intraepithelial Neoplasia

**Subclasses:** [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C27423](http://purl.obolibrary.org/obo/NCIT_C27423) (Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C4840](http://purl.obolibrary.org/obo/NCIT_C4840) (Esophageal Low Grade Intraepithelial Neoplasia), [NCIT:C27429](http://purl.obolibrary.org/obo/NCIT_C27429) (High Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C27428](http://purl.obolibrary.org/obo/NCIT_C27428) (Low Grade Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27425](http://purl.obolibrary.org/obo/NCIT_C27425) (Esophageal High Grade Intraepithelial Neoplasia), [NCIT:C27424](http://purl.obolibrary.org/obo/NCIT_C27424) (Esophageal Glandular Intraepithelial Neoplasia), [NCIT:C27427](http://purl.obolibrary.org/obo/NCIT_C27427) (Low Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C27426](http://purl.obolibrary.org/obo/NCIT_C27426) (High Grade Esophageal Squamous Intraepithelial Neoplasia), [NCIT:C95613](http://purl.obolibrary.org/obo/NCIT_C95613) (Intraepithelial Neoplasia in Barrett Esophagus), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C36704](http://purl.obolibrary.org/obo/NCIT_C36704) (FHIT Gene Inactivation) 54.55%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 54.55%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 54.55%
- Thing 52.66%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38698](http://purl.obolibrary.org/obo/NCIT_C38698) (Hyperviscosity))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38674](http://purl.obolibrary.org/obo/NCIT_C38674) (Widespread Disease))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38667](http://purl.obolibrary.org/obo/NCIT_C38667) (Polymorphic Cellular Infiltrate))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38666](http://purl.obolibrary.org/obo/NCIT_C38666) (Monomorphic Cellular Infiltrate))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38665](http://purl.obolibrary.org/obo/NCIT_C38665) (Chest Pain))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38661](http://purl.obolibrary.org/obo/NCIT_C38661) (Composite Lymphoma))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38660](http://purl.obolibrary.org/obo/NCIT_C38660) (Neoplastic Large B-Lymphocyte with Pale Cytoplasm))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3866](http://purl.obolibrary.org/obo/NCIT_C3866) (Esophageal Leiomyoma))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38658](http://purl.obolibrary.org/obo/NCIT_C38658) (Transformed Peripheral B-Lymphocyte))) 39.90%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38657](http://purl.obolibrary.org/obo/NCIT_C38657) (Neoplastic Immunoblast-Like B-Lymphocyte))) 39.90%


